Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Barton Duell

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Atherosclerosis|December 1, 2018
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemiaLaurens F Reeskamp, John J P Kastelein, Patrick M Moriarty, et al.
Journal of Clinical Lipidology|June 9, 2020
Genetic testing in dyslipidemia: A scientific statement from the National Lipid AssociationEmily E Brown, Amy C Sturm, Marina Cuchel, et al.
Atherosclerosis|August 30, 2023
Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trialsAnne C Goldberg, Maciej Banach, Alberico L Catapano, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 21, 2010
Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysisAndrea E DeBarber, Yana Sandlers, Anuradha S Pappu, et al.
Journal of Clinical Lipidology|September 17, 2022
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid AssociationBruce A Warden, John R Guyton, Adrienne C Kovacs, et al.
Biochimie|July 1, 2018
Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasmaJonas Abdel-Khalik, Peter J Crick, Eylan Yutuc, et al.
Circulation Research|January 4, 2019
Application of PCSK9 Inhibitors in PracticeTina M Kaufman, Bruce A Warden, Jessica Minnier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 14, 2022
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart AssociationP Barton Duell, Francine K Welty, Michael Miller, et al.
Circulation Research|April 29, 2016
PCSK9 Association With Lipoprotein(a)Hagai Tavori, Devon Christian, Jessica Minnier, et al.
Journal of Clinical Lipidology|February 10, 2024
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trialsP Barton Duell, Maciej Banach, Alberico L Catapano, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Atherosclerosis|December 1, 2018
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemiaLaurens F Reeskamp, John J P Kastelein, Patrick M Moriarty, et al.
Journal of Clinical Lipidology|June 9, 2020
Genetic testing in dyslipidemia: A scientific statement from the National Lipid AssociationEmily E Brown, Amy C Sturm, Marina Cuchel, et al.
Atherosclerosis|August 30, 2023
Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trialsAnne C Goldberg, Maciej Banach, Alberico L Catapano, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 21, 2010
Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysisAndrea E DeBarber, Yana Sandlers, Anuradha S Pappu, et al.
Journal of Clinical Lipidology|September 17, 2022
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid AssociationBruce A Warden, John R Guyton, Adrienne C Kovacs, et al.
Biochimie|July 1, 2018
Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasmaJonas Abdel-Khalik, Peter J Crick, Eylan Yutuc, et al.
Circulation Research|January 4, 2019
Application of PCSK9 Inhibitors in PracticeTina M Kaufman, Bruce A Warden, Jessica Minnier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 14, 2022
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart AssociationP Barton Duell, Francine K Welty, Michael Miller, et al.
Circulation Research|April 29, 2016
PCSK9 Association With Lipoprotein(a)Hagai Tavori, Devon Christian, Jessica Minnier, et al.
Journal of Clinical Lipidology|February 10, 2024
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trialsP Barton Duell, Maciej Banach, Alberico L Catapano, et al.
Pageof 9